Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Sabra A.-N.A.; Salem M.B.; William S.; Hammam O.A.; El-Lakkany N.M.

Journal: Experimental Parasitology

Publisher: Academic Press Inc.

Publication Date: August 2022

Volume / Issue: Volume 239

Article No.: 108293

ISSN: 144894

DOI: 10.1016/j.exppara.2022.108293

Scopus: View on Scopus

PubMed: 35667394

Document Type: Article


Authors and Affiliations

Sabra A.-N.A., Professor of Pharmacology, Theodor Bilharz Research Institute, Giza, Egypt; Salem M.B., Lecturer of Pharmacology, Theodor Bilharz Research Institute, Giza, Egypt; William S., Professor of Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Hammam O.A., Professor of Pathology, Theodor Bilharz Research Institute, Giza, Egypt; El-Lakkany N.M., Professor of Pharmacology, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Treatment of schistosomiasis is heavily reliant on the single antischistosomal drug praziquantel (PZQ). The use of synergistic drug-drug interactions is one possible solution, which could be used to mitigate PZQ's poor and variable bioavailability. Itraconazole (ITZ), a triazole antifungal agent, is a potent CYP3A inhibitor that can cause significant drug-drug interactions when used with CYP3A substrates. This study investigates the effect of ITZ as adjuvant therapy with PZQ on worm load, egg deposition and maturation, and the consequent histopathology and biochemical abnormalities in the liver during the immature and mature stages of Schistosoma mansoni (S. mansoni) infection. S. mansoni-infected mice were divided into five groups of eight−ten mice each: (I) infected untreated, (II) infected and treated with PZQ 3 weeks PI, (III) infected and treated with both ITZ and PZQ 3 weeks PI, (IV) infected and treated with PZQ 7 weeks PI, and (V) infected and treated with both ITZ and PZQ 7 weeks PI. All mice were killed by rapid decapitation 9 weeks PI. Data revealed that ITZ in combination with PZQ at both immature and mature stages improved the parasitological criteria of cure, and greatly reduced inflammation, granuloma and fibrotic tissue formation, and apoptosis versus PZQ alone. Furthermore, it showed the greatest impact on improving liver injury and oxidative stress markers. Notably, the effect was considerably stronger at the mature stage of S. mansoni infection. These findings support the notion that ITZ increased PZQ's antischistosomal activity by inhibiting CYP450 expression, potentially reducing PZQ metabolism and increasing systemic exposure. © 2022 Elsevier Inc.


Keywords

Caspase 3; CYP450; Granuloma; Itraconazole; Praziquantal; Schistosoma mansoni; Animals; Anthelmintics; Liver; Mice; Praziquantel; Schistosomiasis mansoni; cytochrome P450; itranox; anthelmintic agent; adjuvant therapy; adult; animal experiment; animal model; animal tissue; anthelmintic activity; antiinflammatory activity; apoptosis; Article; combination drug therapy; controlled study; drug bioavailability; drug blood level; drug efficacy; drug elimination; drug exposure; drug metabolism; drug potency; drug potentiation; histopathology; in vitro study; in vivo study; liver fibrosis; liver granuloma; liver injury; male; monotherapy; mouse; nonhuman; oxidative stress; protein expression; single drug dose; worm burden; animal; pathology


Citation Information

Scopus Citations: 3


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]